Cancer Diagnostics Market is expected to reach USD 26.6 billion by 2026 with CAGR of 11.5%

1
(No Transcript)
2
Cancer Diagnostics Market
MARKET OPPORTUNITY OVER NEXT 5 YEARS
KEY MARKET PLAYERS
By Instruments
CAGR of
2021 2026

• Danaher Corporation (US)
• Becton
• Dickinson and Company (US)
• Bio-Rad Laboratories, Inc. (US.)
• F. Hoffman-La Roche AG (Switzerland)
• QIAGEN N.V. (Netherlands)

CAGR

• Pathology Instruments
• Imaging Instruments
• Biopsy

By Application
North America Europe Asia Pacific Rest of the
World

• Breast Cancer
• Lung Cancer

3
According to market research report "Cancer
Diagnostics Market by Product (Consumables
(Anitibodies, Probes), Instruments (Pathology
Instruments, Imaging Instruments, Biopsy),
Technology (IVD Testing), Application (Breast
Cancer, Lung Cancer), End User (Hospitals) -
Global Forecasts to 2026", published by
MarketsandMarkets, is projected to reach USD
26.6 billion by 2026 from USD 17.2 billion in
2021, at a CAGR of 11.5. Growth of the cancer
diagnostics market is driven mainly by increasing
incidence of cancer and growth in the number of
private diagnostic laboratories. Key
Players Danaher Corporation (US), Becton,
Dickinson and Company (US), Bio-Rad Laboratories,
Inc. (US.), F. Hoffman-La Roche AG (Switzerland),
QIAGEN N.V. (Netherlands), Fujifilm Corporation
(Japan), Aglient Technologies (US) and Thermo
Fisher Scientific Inc. (US) etc. Download PDF
Brochure https//www.marketsandmarkets.com/pdfdo
wnloadNew.asp?id186559121
4
Browse in-depth TOC on "Cancer Diagnostics
Market" 300 - Tables 48 - Figures 280
Pages Consumables accounted for the larger share
of the cancer diagnostics market in 2020 Based on
the product, the cancer diagnostics industry is
segmented into consumables and instruments. In
2020, the instruments segment accounted for the
larger share of the cancer diagnostics market.
The large share of this segment can be attributed
to the increasing incidence of cancer and
increasing number of cancer diagnostics test. By
technology, the IVD testing segment accounted for
the largest industry share in 2020 Based on the
technology, the cancer diagnostics market is
segmented into IVD testing, imaging based
technique and biopsy technique. The IVD testing
segment accounted for the largest market share in
2020. The increasing incidence of cancer and
technological advancement are major driving
factors for this market. Request Sample Pages
https//www.marketsandmarkets.com/requestsampleNe
w.asp?id186559121
5
Hospitals are the largest end-users of the cancer
diagnostics market Based on end-users, the cancer
diagnostics market is segmented into hospitals
and diagnostic laboratories. The hospitals
segment accounted for the largest market share in
2020 due to the rising number of in-house
diagnostic procedures performed in hospitals,
growing awareness regarding early diagnosis, and
the availability of reimbursements. North
America dominates the global Lung cancer
diagnostics market The cancer diagnostics market
is segmented into four major regional segments,
namely, North America, Europe, Asia Pacific, and
the Rest of the World. In 2020, North America
accounted for the largest share of the cancer
diagnostics market. The large share of North
America can be attributed to factors such as the
increasing incidences of cancer, growing
awareness early diagnosis and technological
advancement.
6
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies'
revenues. Currently servicing 7500 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions. Our 850 fulltime analyst and
SMEs at MarketsandMarkets are tracking global
high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve. MarketsandMarkets's flagship
competitive intelligence and market research
platform, "Knowledge Store" connects over 200,000
markets and entire value chains for deeper
understanding of the unmet insights along with
market sizing and forecasts of niche markets.
7
Contact Mr. Aashish Mehra MarketsandMarkets
INC. 630 Dundee Road Suite 430 Northbrook, IL
60062 USA 1-888-600-6441 Email
sales_at_marketsandmarkets.com View Full Report -
https//www.marketsandmarkets.com/Market-Reports/c
ancer-diagnostics-market-186559121.html